tiprankstipranks
Advertisement
Advertisement

TSE:MRVL Stock Latest News

Marvel Biosciences Advances MB-204 With High-Bioavailability Pediatric Liquid Formulations
Company AnnouncementsMarvel Biosciences Advances MB-204 With High-Bioavailability Pediatric Liquid Formulations
20d ago
Marvel Biosciences Advances Pediatric MB-204 Formulations for Neurodevelopmental Disorders
PremiumCompany Announcements
Marvel Biosciences Advances Pediatric MB-204 Formulations for Neurodevelopmental Disorders
20d ago
Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
PremiumCompany Announcements
Marvel Biosciences Lowers Conversion Price on Proposed Debenture Financing
22d ago
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
PremiumCompany Announcements
Marvel Biosciences to Raise Up to $500,000 via Convertible Debenture Offering
27d ago
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
PremiumCompany Announcements
Marvel Biosciences Wins Non-Dilutive Backing for MB-204 Phase I Trial
28d ago
Marvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
PremiumCompany AnnouncementsMarvel Biosciences Wins Alberta Funding to Advance MB-204 Into Phase I Trials
1M ago
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
Premium
Company Announcements
Marvel Biosciences Taps Novotech to Run Phase I Trial of Lead Neurodrug MB-204
1M ago
Marvel Biosciences Wins Key U.S. Patent for Lead Neurology Drug MB-204
Premium
Company Announcements
Marvel Biosciences Wins Key U.S. Patent for Lead Neurology Drug MB-204
2M ago
Marvel Biosciences Backs European Purine Meeting to Bolster A2A Neurology Strategy
PremiumCompany Announcements
Marvel Biosciences Backs European Purine Meeting to Bolster A2A Neurology Strategy
2M ago
Marvel Biosciences Grants Deferred Share Units to Independent Directors
PremiumCompany Announcements
Marvel Biosciences Grants Deferred Share Units to Independent Directors
3M ago
Marvel Biosciences Wins NRC IRAP Support for Pediatric Liquid Form of Lead Neurodrug
PremiumCompany Announcements
Marvel Biosciences Wins NRC IRAP Support for Pediatric Liquid Form of Lead Neurodrug
3M ago
Marvel Biosciences Wins Key Japanese Patent for Lead Neurology Drug MB-204
PremiumCompany Announcements
Marvel Biosciences Wins Key Japanese Patent for Lead Neurology Drug MB-204
3M ago
Marvel Biosciences Issues Deferred Share Units to Directors
PremiumCompany AnnouncementsMarvel Biosciences Issues Deferred Share Units to Directors
6M ago
Marvel Biosciences Accelerates Warrant Expiry Amid Strong Shareholder Confidence
Premium
Company Announcements
Marvel Biosciences Accelerates Warrant Expiry Amid Strong Shareholder Confidence
7M ago
Marvel Biosciences Secures Chinese Patent for Lead Drug Candidate MB-204
Premium
Company Announcements
Marvel Biosciences Secures Chinese Patent for Lead Drug Candidate MB-204
9M ago
Marvel Biosciences Grants Deferred Share Units to Directors
PremiumCompany Announcements
Marvel Biosciences Grants Deferred Share Units to Directors
9M ago
Marvel Biosciences Completes $1 Million Private Placement to Advance Neurological Research
PremiumCompany Announcements
Marvel Biosciences Completes $1 Million Private Placement to Advance Neurological Research
12M ago
Marvel Biosciences Closes Second Tranche of Private Placement
PremiumCompany Announcements
Marvel Biosciences Closes Second Tranche of Private Placement
1y ago
Marvel Biosciences’ MB-204 Shows Promising Results in Rett Syndrome Study
PremiumCompany Announcements
Marvel Biosciences’ MB-204 Shows Promising Results in Rett Syndrome Study
1y ago
Marvel Biosciences to Present MB-204 Research at IRSF Meeting
PremiumCompany AnnouncementsMarvel Biosciences to Present MB-204 Research at IRSF Meeting
1y ago
Marvel Biosciences to Present Alzheimer’s Research at 2025 International Conference
Premium
Company Announcements
Marvel Biosciences to Present Alzheimer’s Research at 2025 International Conference
1y ago
Marvel Biosciences Secures $1 Million in Private Placement
Premium
Company Announcements
Marvel Biosciences Secures $1 Million in Private Placement
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >